{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:04:18Z","timestamp":1780319058376,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To identify clinical and laboratory risk factors for invasive infection in febrile oncology patients seen in the Pediatric Emergency Department, depending on the type of cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a prospective observational study of febrile oncology patients seen between 2016 and 2023 at the Pediatric Emergency Department of a tertiary teaching hospital. Invasive infection was defined microbiologically (isolation of a bacterial pathogen in sterile fluid or a commensal bacterial species in 2 different blood cultures) or clinically (death, meeting Phoenix criteria for sepsis, receiving inotropic support, or developing acute complications or sequelae). We performed separate multivariate analyses for hematologic cancers and solid tumors. Hematologic cancers were further classified considering the myelotoxicity of the chemotherapy received. We classified the following as high-risk hematologic cancers: acute lymphoblastic leukemia and non-Hodgkin lymphoma in the induction, reinduction, or consolidation phase or relapse, and acute myeloid leukemia in any phase<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We included 471 episodes: 306 hematologic cancers and 165 solid tumors. The median age was 4 years (interquartile range: 2 to 10) and the median duration of fever was 2 hours (interquartile range: 1 to 3). Invasive infections were diagnosed in 69 cases (14.6%). The rate was higher among patients with high-risk hematologic cancers (n=45, 23.2%), than among those with solid tumors (n=18, 10.9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.002) or with low-risk hematologic cancers (n=6, 5.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Among patients with hematological cancers, presenting a high-risk cancer (OR: 6.006; 95% CI: 2.459-18.200) and elevated procalcitonin levels (OR: 1.668; 95% CI: 1.205-2.571) were predictors of invasive infection [AUC for the model: 0.718 (95% CI: 0.640-0.795)]. Only age (OR: 1.145; 95% CI: 1.036-1.267) was found to be an independent risk factor in patients with solid tumors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In patients with hematologic cancers and very recent onset fever, the type of cancer and procalcitonin level are useful for predicting the risk of invasive infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pec.0000000000003571","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:04:16Z","timestamp":1770653056000},"page":"440-445","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors for Invasive Infection in Febrile Oncology Patients Related to Cancer Type"],"prefix":"10.1097","volume":"42","author":[{"given":"Borja","family":"Gomez","sequence":"first","affiliation":[{"name":"Department of Pediatric Emergency, Hospital Universitario Cruces, BioBizkaia Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Quintana","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Cruces"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Cruces"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"L\u00f3pez-Almaraz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Hemato-Oncology Unit, Hospital Universitario Cruces, BioBizkaia Health Research Institute, Barakaldo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Almarza","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Cruces"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Mintegi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Emergency, Hospital Universitario Cruces, BioBizkaia Health Research Institute"},{"name":"Department of Pediatrics, Universidad del Pais Vasco, Bilbao, Basque Country, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"R1-20260601","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/INF.0000000000000326","article-title":"A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study","volume":"33","author":"Agyeman","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R2-20260601","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MPH.0b013e3181b1edc6","article-title":"Etiology and clinical course of febrile neutropenia in children with cancer","volume":"31","author":"Hakim","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R3-20260601","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/522533","article-title":"A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation","volume":"45","author":"Castagnola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R4-20260601","doi-asserted-by":"crossref","first-page":"e27634","DOI":"10.1002\/pbc.27634","article-title":"Nonneutropenic fever in children with cancer: a scoping review of management and outcome","volume":"66","author":"Allaway","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20260601","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.20.00591","article-title":"Prospective implementation of a risk prediction model for bloodstream infection safely reduces antibiotic usage in febrile pediatric cancer patients without severe neutropenia","volume":"38","author":"Esbenshade","year":"2020","journal-title":"J Clin Oncol"},{"key":"R6-20260601","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/pbc.25275","article-title":"Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer","volume":"62","author":"Esbenshade","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20260601","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/MPH.0000000000002201","article-title":"Bacteremia in febrile, non-neutropenic, and well-appearing children with cancer","volume":"44","author":"Beauchemin","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"R8-20260601","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1038\/s41598-022-11576-z","article-title":"A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia","volume":"12","author":"Alali","year":"2022","journal-title":"Sci Rep"},{"key":"R9-20260601","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jpids\/piac080","article-title":"Predictors of septic shock or bacteremia in children experiencing febrile neutropenia post-chemotherapy","volume":"11","author":"Avil\u00e9s-Robles","year":"2022","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R10-20260601","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/INF.0b013e3181c3f6f0","article-title":"Risk prediction in pediatric cancer patients with fever and neutropenia","volume":"29","author":"Hakim","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20260601","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1038\/bjc.2016.137","article-title":"Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis","volume":"114","author":"Phillips","year":"2016","journal-title":"Br J Cancer"},{"key":"R12-20260601","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.htct.2021.08.005","article-title":"Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy","volume":"45","author":"Lima","year":"2023","journal-title":"Hematol Transfus Cell Ther"},{"key":"R13-20260601","doi-asserted-by":"crossref","first-page":"100220","DOI":"10.1016\/j.eclinm.2019.11.013","article-title":"Australian PICNICC study group and the PREDICT network. Risk stratification in children with cancer and febrile neutropenia: a national, prospective, multicentre validation of nine clinical decision rules","volume":"18","author":"Haeusler","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R14-20260601","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"key":"R15-20260601","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"R16-20260601","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/apa.17369","article-title":"Characteristics of oncology patients with fever and invasive bacterial infections diagnosed","volume":"113","author":"Gomez","year":"2024","journal-title":"Acta Paediatr"},{"key":"R17-20260601","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/PEC.0b013e3181d6db37","article-title":"The pediatric assessment triangle: a novel approach for the rapid evaluation of children","volume":"26","author":"Dieckmann","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"R18-20260601","doi-asserted-by":"crossref","first-page":"e1173","DOI":"10.1542\/peds.2014-3738","article-title":"Heart rates in hospitalized children by age and body temperature","volume":"135","author":"Daymont","year":"2015","journal-title":"Pediatrics"},{"key":"R20-20260601","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jama.2024.0196","article-title":"Development and validation of the phoenix criteria for pediatric sepsis and septic shock","volume":"331","author":"Sanchez-Pinto","year":"2024","journal-title":"JAMA"},{"key":"R21-20260601","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.2024.0179","article-title":"Society of Critical Care Medicine Pediatric Sepsis Definition Task Force. International Consensus Criteria for Pediatric Sepsis and Septic Shock","volume":"331","author":"Schlapbach","year":"2024","journal-title":"JAMA"},{"key":"R22-20260601","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2019.06.008","article-title":"Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor","volume":"79","author":"Delebarre","year":"2019","journal-title":"J Infect"},{"key":"R23-20260601","doi-asserted-by":"crossref","first-page":"e2021052228","DOI":"10.1542\/peds.2021-052228","article-title":"Subcommittee on febrile infants. Evaluation and management of well-appearing febrile infants 8 to 60 days old","volume":"148","author":"Pantell","year":"2021","journal-title":"Pediatrics"},{"key":"R24-20260601","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2352-4642(21)00337-0","article-title":"Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer","volume":"6","author":"Delebarre","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"R25-20260601","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1097\/pq9.0000000000000771","article-title":"Outpatient management of fever and neutropenia in low-risk children with solid tumors: a quality improvement initiative","volume":"9","author":"Bourgeois","year":"2024","journal-title":"Pediatr Qual Saf"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000003571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:01:41Z","timestamp":1780315301000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000003571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000003571","relation":{},"ISSN":["0749-5161","1535-1815"],"issn-type":[{"value":"0749-5161","type":"print"},{"value":"1535-1815","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"2025-10-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}